StockData
Fennec Pharmaceuticals Inc. logo

Fennec Pharmaceuticals Inc. (FENC) stock

FENCNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/3074% above fair value
$13.58+0.82 (+6.43%)

Close on Nov 17, 2026Market cap $476.21MP/E –Yield –

Fennec Pharmaceuticals EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Fennec Pharmaceuticals's EV/EBITDA was 54.4× on Apr 30, 2025.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2025Apr 30, 202554.4×−24.6
2024Dec 31, 202479.0×–

More Fennec Pharmaceuticals figures

See a number that looks wrong?